Monogram Biosciences, Inc.
Healthcare · In Vitro & In Vivo Diagnostic Substances · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Material events
SEC Form 8-K · most recent- Entered a material agreement · Delisting / listing-standard notice · Unregistered equity sale · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsAug 10, 2009
- Entered a material agreement · Director / officer change · Other material eventJun 24, 2009
- Results of operationsMay 6, 2009
- Results of operationsFeb 12, 2009
- Results of operations · Other material eventJan 20, 2009
- Delisting / listing-standard noticeDec 9, 2008
- Other material eventNov 4, 2008
- Results of operations · Other material eventOct 27, 2008
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AOct 7, 2009
- 4Oct 6, 2009
- SC 13G/ASep 10, 2009
- 15-12GFORM 15Aug 24, 2009
- RWREQUEST FOR WITHDRAWLAug 21, 2009
- RWREQUEST FOR WITHDRAWLAug 21, 2009
- EFFECTAug 20, 2009
- POS AMPOST-EFFECTIVE AMENDMENT NO.1 TO FORM S-3Aug 19, 2009
- S-8 POSPOST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8Aug 19, 2009
- EFFECTAug 18, 2009
- EFFECTAug 18, 2009
- EFFECTAug 18, 2009
- EFFECTAug 18, 2009
- EFFECTAug 18, 2009
- EFFECTAug 18, 2009
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.